Bicara Therapeutics (BCAX) Property, Plant & Equipment (Net) (2023 - 2026)

Bicara Therapeutics (BCAX) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 642,333.36
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 31.48 Mn
10 Bicara Therapeutics 1.64 Bn 1.64 Bn - 346,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 346,000.00
Mar 31, 2026 346,000.00
Dec 31, 2025 330,000.00
Dec 31, 2025 330,000.00
Sep 30, 2025 135,000.00
Sep 30, 2025 135,000.00
Jun 30, 2025 117,000.00
Jun 30, 2025 117,000.00
Mar 31, 2025 136,000.00
Mar 31, 2025 136,000.00
Dec 31, 2024 155,000.00
Dec 31, 2024 155,000.00
Sep 30, 2024 130,000.00
Sep 30, 2024 130,000.00
Dec 31, 2023 202,000.00
Dec 31, 2023 202,000.00